Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-22

Clinical Trial Update: Establishing Best Treatment Strategy for T4 Esophageal Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating treatment strategies for patients with T4 esophageal cancer; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Cheng-Kung University Hospital | Conditions: Esophageal Cancer TNM Staging Primary Tumor (T) T4 | Phase 1, Phase 2 | Status: RECRUITING